Datasets:
id int64 | nra_level string | country_id string | product_type string | regulatory_category string | dosage_form_class string | therapeutic_area string | on_national_EML int64 | applicant_type string | manufacturer_origin string | WHO_prequalified int64 | submission_year int64 | dossier_format string | reliance_pathway int64 | joint_assessment int64 | GMP_inspection_done int64 | bioequivalence_study int64 | registration_fee_usd int64 | dossier_quality_score int64 | registration_days int64 | outcome string | queries_raised int64 | renewal_required int64 | validity_years int64 | unregistered_market_share_pct float64 | patient_access_impact string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ML2_standard | REG_005 | generic_tablet_capsule | generic | solid_oral | oncology | 0 | importer_distributor | India | 0 | 2,024 | national_format | 0 | 0 | 0 | 0 | 815 | 61 | 465 | approved | 1 | 1 | 5 | 48.2 | delayed |
2 | ML2_standard | REG_004 | traditional_herbal | herbal | solid_oral | dermatology | 0 | multinational | China | 1 | 2,021 | national_format | 0 | 0 | 0 | 0 | 604 | 55 | 72 | approved | 3 | 1 | 5 | 55.4 | unavailable |
3 | ML2_standard | REG_024 | generic_tablet_capsule | generic | solid_oral | oncology | 1 | importer_distributor | India | 0 | 2,020 | national_format | 0 | 0 | 0 | 0 | 646 | 44 | 49 | query_raised | 5 | 1 | 3 | 45.4 | adequate |
4 | ML2_standard | REG_015 | biological_vaccine | biological | parenteral | NCD_cardiovascular | 1 | multinational | India | 0 | 2,023 | ACTD | 0 | 0 | 0 | 0 | 909 | 40 | 44 | approved | 3 | 1 | 5 | 56.7 | delayed |
5 | ML2_standard | REG_013 | generic_injection | generic | parenteral | TB | 1 | multinational | India | 0 | 2,024 | national_format | 0 | 0 | 0 | 0 | 575 | 45 | 82 | withdrawn | 2 | 1 | 3 | 35.5 | unavailable |
6 | ML2_standard | REG_027 | generic_tablet_capsule | generic | solid_oral | paediatric | 0 | importer_distributor | Europe | 0 | 2,022 | CTD | 0 | 0 | 0 | 1 | 514 | 40 | 562 | query_raised | 2 | 0 | 5 | 53.1 | adequate |
7 | ML2_standard | REG_015 | generic_tablet_capsule | generic | solid_oral | NCD_diabetes | 0 | importer_distributor | China | 0 | 2,022 | ACTD | 0 | 1 | 0 | 0 | 761 | 35 | 31 | query_raised | 4 | 0 | 3 | 40.3 | delayed |
8 | ML2_standard | REG_030 | innovator_branded | innovator | solid_oral | NCD_cardiovascular | 0 | regional_manufacturer | other | 0 | 2,023 | CTD | 0 | 0 | 1 | 0 | 505 | 32 | 359 | query_raised | 6 | 1 | 5 | 51.8 | unavailable |
9 | ML2_standard | REG_052 | generic_tablet_capsule | generic | solid_oral | ARV_HIV | 0 | multinational | India | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 760 | 52 | 165 | approved | 2 | 1 | 5 | 41.2 | unavailable |
10 | ML2_standard | REG_002 | generic_suspension_syrup | generic | liquid_oral | paediatric | 1 | multinational | other | 0 | 2,022 | ACTD | 0 | 0 | 0 | 0 | 746 | 50 | 491 | approved | 3 | 0 | 5 | 35.4 | unavailable |
11 | ML2_standard | REG_046 | generic_tablet_capsule | generic | solid_oral | antimalarial | 0 | importer_distributor | India | 0 | 2,023 | abbreviated | 0 | 0 | 0 | 0 | 777 | 26 | 1,513 | query_raised | 3 | 1 | 5 | 53.4 | unavailable |
12 | ML2_standard | REG_018 | generic_tablet_capsule | generic | solid_oral | TB | 0 | multinational | India | 0 | 2,021 | CTD | 1 | 0 | 1 | 0 | 1,043 | 49 | 131 | approved | 2 | 1 | 3 | 70.9 | delayed |
13 | ML2_standard | REG_052 | generic_tablet_capsule | generic | solid_oral | NCD_cardiovascular | 1 | importer_distributor | India | 0 | 2,020 | abbreviated | 1 | 0 | 0 | 0 | 686 | 51 | 261 | rejected | 2 | 0 | 5 | 47.6 | delayed |
14 | ML2_standard | REG_014 | generic_tablet_capsule | generic | solid_oral | TB | 1 | local_manufacturer | India | 0 | 2,022 | CTD | 0 | 0 | 0 | 0 | 939 | 68 | 241 | approved | 5 | 1 | 3 | 57.8 | unavailable |
15 | ML2_standard | REG_050 | generic_injection | generic | parenteral | antibiotic | 1 | importer_distributor | India | 0 | 2,021 | abbreviated | 0 | 0 | 0 | 0 | 556 | 48 | 1,035 | approved | 3 | 1 | 5 | 50.7 | unavailable |
16 | ML2_standard | REG_028 | generic_tablet_capsule | generic | solid_oral | NCD_diabetes | 0 | multinational | India | 0 | 2,023 | ACTD | 0 | 0 | 0 | 0 | 856 | 51 | 186 | approved | 1 | 0 | 5 | 48.7 | unavailable |
17 | ML2_standard | REG_010 | medical_device_IVD | device | device | analgesic | 0 | local_manufacturer | India | 0 | 2,024 | abbreviated | 0 | 0 | 0 | 0 | 319 | 67 | 992 | approved | 4 | 1 | 5 | 52.8 | adequate |
18 | ML2_standard | REG_022 | biosimilar | biosimilar | parenteral | dermatology | 1 | importer_distributor | India | 0 | 2,023 | national_format | 1 | 0 | 1 | 0 | 630 | 45 | 328 | approved | 2 | 1 | 3 | 30.1 | unavailable |
19 | ML2_standard | REG_053 | biological_vaccine | biological | parenteral | ARV_HIV | 1 | importer_distributor | other | 0 | 2,023 | national_format | 1 | 0 | 0 | 0 | 776 | 64 | 325 | rejected | 2 | 1 | 5 | 67.2 | delayed |
20 | ML2_standard | REG_028 | generic_injection | generic | parenteral | antimalarial | 1 | public_sector_agency | local_SSA | 0 | 2,020 | CTD | 0 | 0 | 0 | 0 | 878 | 52 | 1,223 | approved | 4 | 1 | 5 | 69.5 | adequate |
21 | ML2_standard | REG_053 | generic_tablet_capsule | generic | solid_oral | antibiotic | 1 | local_manufacturer | Europe | 0 | 2,022 | ACTD | 0 | 0 | 0 | 1 | 729 | 71 | 30 | approved | 5 | 1 | 5 | 50.1 | delayed |
22 | ML2_standard | REG_052 | generic_suspension_syrup | generic | liquid_oral | analgesic | 0 | public_sector_agency | China | 0 | 2,024 | CTD | 0 | 0 | 0 | 1 | 1,060 | 52 | 74 | approved | 2 | 1 | 5 | 35 | delayed |
23 | ML2_standard | REG_039 | generic_injection | generic | parenteral | antibiotic | 1 | local_manufacturer | other | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 779 | 57 | 85 | approved | 6 | 1 | 3 | 64.6 | unavailable |
24 | ML2_standard | REG_003 | generic_tablet_capsule | generic | solid_oral | NCD_diabetes | 1 | multinational | other | 1 | 2,021 | CTD | 0 | 0 | 0 | 1 | 395 | 38 | 90 | approved | 2 | 1 | 5 | 56.6 | unavailable |
25 | ML2_standard | REG_018 | generic_suspension_syrup | generic | liquid_oral | NCD_diabetes | 0 | importer_distributor | other | 0 | 2,024 | CTD | 0 | 0 | 0 | 1 | 880 | 48 | 165 | approved | 1 | 0 | 5 | 51.9 | delayed |
26 | ML2_standard | REG_031 | generic_tablet_capsule | generic | solid_oral | antimalarial | 0 | importer_distributor | other | 0 | 2,023 | national_format | 0 | 0 | 0 | 0 | 542 | 56 | 343 | approved | 7 | 1 | 3 | 45.8 | delayed |
27 | ML2_standard | REG_048 | generic_tablet_capsule | generic | solid_oral | dermatology | 0 | local_manufacturer | local_SSA | 0 | 2,023 | national_format | 0 | 0 | 1 | 1 | 929 | 35 | 429 | query_raised | 4 | 1 | 5 | 45.6 | adequate |
28 | ML2_standard | REG_052 | generic_injection | generic | parenteral | analgesic | 1 | local_manufacturer | other | 0 | 2,021 | abbreviated | 0 | 0 | 0 | 0 | 725 | 44 | 526 | approved | 1 | 1 | 5 | 70.5 | adequate |
29 | ML2_standard | REG_042 | generic_tablet_capsule | generic | solid_oral | NCD_cardiovascular | 0 | public_sector_agency | local_SSA | 0 | 2,022 | abbreviated | 0 | 0 | 0 | 1 | 940 | 51 | 127 | query_raised | 5 | 0 | 3 | 33.8 | unavailable |
30 | ML2_standard | REG_017 | generic_suspension_syrup | generic | liquid_oral | analgesic | 0 | importer_distributor | India | 0 | 2,022 | CTD | 0 | 0 | 0 | 0 | 759 | 57 | 495 | withdrawn | 5 | 1 | 5 | 45.8 | delayed |
31 | ML2_standard | REG_051 | generic_tablet_capsule | generic | solid_oral | NCD_diabetes | 0 | multinational | India | 0 | 2,020 | ACTD | 0 | 0 | 1 | 1 | 786 | 60 | 636 | approved | 2 | 1 | 3 | 39.6 | adequate |
32 | ML2_standard | REG_006 | generic_tablet_capsule | generic | solid_oral | analgesic | 1 | local_manufacturer | local_SSA | 0 | 2,022 | CTD | 0 | 0 | 0 | 1 | 867 | 57 | 30 | approved | 2 | 1 | 5 | 51.6 | adequate |
33 | ML2_standard | REG_045 | generic_tablet_capsule | generic | solid_oral | antimalarial | 0 | regional_manufacturer | Europe | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 585 | 48 | 755 | approved | 5 | 1 | 3 | 56.4 | delayed |
34 | ML2_standard | REG_045 | generic_tablet_capsule | generic | solid_oral | antimalarial | 1 | multinational | India | 0 | 2,024 | national_format | 0 | 0 | 0 | 1 | 848 | 34 | 66 | approved | 1 | 1 | 5 | 58.9 | adequate |
35 | ML2_standard | REG_031 | traditional_herbal | herbal | solid_oral | mental_health | 0 | importer_distributor | India | 1 | 2,023 | CTD | 0 | 0 | 1 | 0 | 1,038 | 60 | 30 | approved | 5 | 1 | 5 | 46.8 | delayed |
36 | ML2_standard | REG_051 | innovator_branded | innovator | solid_oral | antimalarial | 0 | local_manufacturer | India | 0 | 2,022 | national_format | 0 | 0 | 0 | 0 | 1,145 | 34 | 1,232 | rejected | 6 | 1 | 5 | 42.5 | unavailable |
37 | ML2_standard | REG_028 | generic_tablet_capsule | generic | solid_oral | antibiotic | 0 | multinational | other | 0 | 2,024 | abbreviated | 0 | 0 | 0 | 0 | 630 | 59 | 1,320 | approved | 2 | 1 | 3 | 54.2 | delayed |
38 | ML2_standard | REG_002 | generic_tablet_capsule | generic | solid_oral | dermatology | 1 | importer_distributor | other | 0 | 2,021 | CTD | 0 | 0 | 0 | 1 | 558 | 56 | 2,145 | approved | 1 | 1 | 5 | 49.7 | unavailable |
39 | ML2_standard | REG_006 | locally_manufactured | local | solid_oral | dermatology | 0 | multinational | India | 0 | 2,023 | CTD | 0 | 0 | 0 | 0 | 701 | 48 | 83 | rejected | 3 | 1 | 5 | 48.5 | adequate |
40 | ML2_standard | REG_033 | generic_tablet_capsule | generic | solid_oral | dermatology | 0 | multinational | India | 0 | 2,021 | ACTD | 0 | 0 | 0 | 0 | 1,144 | 54 | 281 | approved | 5 | 1 | 5 | 47.7 | adequate |
41 | ML2_standard | REG_020 | WHO_prequalified_generic | WHO_PQ | solid_oral | antibiotic | 1 | public_sector_agency | India | 1 | 2,023 | CTD | 0 | 1 | 0 | 0 | 850 | 58 | 33 | approved | 2 | 0 | 5 | 13.5 | delayed |
42 | ML2_standard | REG_046 | medical_device_IVD | device | device | antibiotic | 1 | multinational | India | 0 | 2,023 | national_format | 0 | 0 | 0 | 0 | 559 | 46 | 30 | withdrawn | 1 | 1 | 3 | 47.2 | delayed |
43 | ML2_standard | REG_027 | medical_device_IVD | device | device | NCD_cardiovascular | 1 | importer_distributor | China | 0 | 2,023 | ACTD | 0 | 0 | 0 | 0 | 976 | 52 | 30 | approved | 7 | 1 | 5 | 53.5 | unavailable |
44 | ML2_standard | REG_032 | traditional_herbal | herbal | solid_oral | analgesic | 1 | importer_distributor | India | 0 | 2,022 | CTD | 1 | 0 | 0 | 0 | 981 | 52 | 77 | approved | 4 | 1 | 3 | 56.2 | delayed |
45 | ML2_standard | REG_050 | generic_tablet_capsule | generic | solid_oral | mental_health | 0 | importer_distributor | other | 0 | 2,022 | ACTD | 0 | 0 | 0 | 0 | 916 | 41 | 792 | query_raised | 5 | 1 | 3 | 41.4 | unavailable |
46 | ML2_standard | REG_052 | biological_vaccine | biological | parenteral | dermatology | 0 | importer_distributor | local_SSA | 0 | 2,023 | ACTD | 0 | 0 | 0 | 0 | 828 | 53 | 94 | approved | 3 | 1 | 5 | 64.5 | adequate |
47 | ML2_standard | REG_038 | generic_tablet_capsule | generic | solid_oral | oncology | 1 | public_sector_agency | India | 0 | 2,022 | ACTD | 0 | 0 | 1 | 1 | 903 | 48 | 1,002 | query_raised | 2 | 1 | 5 | 50.1 | delayed |
48 | ML2_standard | REG_044 | locally_manufactured | local | solid_oral | maternal_reproductive | 0 | importer_distributor | India | 0 | 2,024 | CTD | 0 | 0 | 1 | 0 | 924 | 34 | 159 | rejected | 5 | 0 | 3 | 50.8 | adequate |
49 | ML2_standard | REG_018 | generic_tablet_capsule | generic | solid_oral | antibiotic | 1 | multinational | India | 0 | 2,024 | CTD | 0 | 0 | 0 | 1 | 296 | 37 | 273 | rejected | 1 | 1 | 3 | 50.4 | delayed |
50 | ML2_standard | REG_030 | generic_tablet_capsule | generic | solid_oral | oncology | 1 | regional_manufacturer | India | 0 | 2,021 | CTD | 0 | 0 | 0 | 1 | 1,031 | 51 | 224 | approved | 5 | 1 | 3 | 34.9 | delayed |
51 | ML2_standard | REG_041 | innovator_branded | innovator | solid_oral | analgesic | 0 | multinational | India | 0 | 2,023 | CTD | 0 | 0 | 0 | 0 | 617 | 49 | 206 | approved | 3 | 1 | 3 | 46.8 | delayed |
52 | ML2_standard | REG_043 | traditional_herbal | herbal | solid_oral | ARV_HIV | 1 | local_manufacturer | other | 1 | 2,021 | ACTD | 0 | 0 | 0 | 0 | 546 | 32 | 109 | approved | 2 | 1 | 3 | 72.8 | adequate |
53 | ML2_standard | REG_051 | generic_tablet_capsule | generic | solid_oral | maternal_reproductive | 0 | public_sector_agency | India | 0 | 2,021 | ACTD | 0 | 0 | 0 | 0 | 898 | 57 | 108 | approved | 4 | 0 | 5 | 50.9 | delayed |
54 | ML2_standard | REG_043 | generic_tablet_capsule | generic | solid_oral | maternal_reproductive | 1 | multinational | India | 0 | 2,023 | CTD | 0 | 0 | 0 | 0 | 366 | 45 | 112 | approved | 4 | 1 | 3 | 67.4 | adequate |
55 | ML2_standard | REG_028 | generic_tablet_capsule | generic | solid_oral | paediatric | 1 | importer_distributor | local_SSA | 0 | 2,024 | abbreviated | 0 | 0 | 1 | 0 | 710 | 52 | 298 | approved | 0 | 1 | 5 | 47.8 | unavailable |
56 | ML2_standard | REG_009 | generic_tablet_capsule | generic | solid_oral | mental_health | 1 | multinational | local_SSA | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 288 | 51 | 651 | withdrawn | 4 | 1 | 5 | 57.5 | delayed |
57 | ML2_standard | REG_035 | generic_injection | generic | parenteral | dermatology | 1 | local_manufacturer | China | 0 | 2,024 | national_format | 0 | 0 | 0 | 1 | 890 | 30 | 531 | approved | 3 | 1 | 5 | 34.1 | adequate |
58 | ML2_standard | REG_032 | generic_tablet_capsule | generic | solid_oral | ARV_HIV | 1 | public_sector_agency | China | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 902 | 53 | 1,021 | withdrawn | 1 | 1 | 3 | 48.9 | adequate |
59 | ML2_standard | REG_017 | biological_vaccine | biological | parenteral | dermatology | 1 | multinational | USA | 0 | 2,023 | abbreviated | 0 | 0 | 0 | 0 | 1,019 | 27 | 78 | approved | 2 | 0 | 5 | 34.9 | unavailable |
60 | ML2_standard | REG_034 | medical_device_IVD | device | device | mental_health | 1 | importer_distributor | China | 0 | 2,024 | abbreviated | 0 | 0 | 0 | 0 | 760 | 26 | 606 | approved | 2 | 0 | 5 | 44.6 | adequate |
61 | ML2_standard | REG_047 | WHO_prequalified_generic | WHO_PQ | solid_oral | ARV_HIV | 1 | importer_distributor | other | 1 | 2,024 | CTD | 1 | 0 | 1 | 0 | 660 | 56 | 41 | approved | 6 | 1 | 3 | 60 | unavailable |
62 | ML2_standard | REG_046 | generic_suspension_syrup | generic | liquid_oral | NCD_cardiovascular | 0 | multinational | India | 0 | 2,023 | ACTD | 0 | 0 | 0 | 0 | 577 | 37 | 873 | approved | 5 | 1 | 5 | 64.4 | delayed |
63 | ML2_standard | REG_034 | locally_manufactured | local | solid_oral | antimalarial | 1 | public_sector_agency | China | 1 | 2,024 | ACTD | 0 | 0 | 0 | 0 | 1,351 | 49 | 134 | query_raised | 5 | 1 | 5 | 35.7 | unavailable |
64 | ML2_standard | REG_019 | generic_tablet_capsule | generic | solid_oral | antibiotic | 0 | importer_distributor | other | 0 | 2,021 | abbreviated | 0 | 0 | 0 | 0 | 827 | 51 | 478 | approved | 2 | 1 | 3 | 49.8 | delayed |
65 | ML2_standard | REG_045 | generic_tablet_capsule | generic | solid_oral | paediatric | 1 | importer_distributor | local_SSA | 0 | 2,022 | national_format | 0 | 0 | 0 | 0 | 919 | 22 | 706 | query_raised | 1 | 1 | 3 | 30 | adequate |
66 | ML2_standard | REG_030 | medical_device_IVD | device | device | oncology | 1 | importer_distributor | other | 0 | 2,023 | abbreviated | 0 | 0 | 0 | 0 | 1,087 | 45 | 1,168 | approved | 4 | 1 | 5 | 33.1 | unavailable |
67 | ML2_standard | REG_037 | traditional_herbal | herbal | solid_oral | mental_health | 1 | local_manufacturer | India | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 423 | 39 | 1,389 | approved | 3 | 1 | 3 | 46.1 | adequate |
68 | ML2_standard | REG_017 | innovator_branded | innovator | solid_oral | paediatric | 1 | regional_manufacturer | other | 0 | 2,022 | ACTD | 0 | 0 | 0 | 0 | 796 | 30 | 122 | approved | 2 | 1 | 5 | 55.5 | adequate |
69 | ML2_standard | REG_008 | generic_suspension_syrup | generic | liquid_oral | NCD_cardiovascular | 1 | multinational | India | 0 | 2,023 | abbreviated | 0 | 0 | 0 | 0 | 877 | 50 | 288 | query_raised | 2 | 1 | 3 | 63.6 | adequate |
70 | ML2_standard | REG_011 | traditional_herbal | herbal | solid_oral | oncology | 0 | regional_manufacturer | India | 0 | 2,021 | abbreviated | 0 | 0 | 0 | 0 | 877 | 38 | 30 | query_raised | 5 | 1 | 5 | 37.8 | delayed |
71 | ML2_standard | REG_030 | generic_tablet_capsule | generic | solid_oral | oncology | 0 | public_sector_agency | local_SSA | 0 | 2,024 | ACTD | 0 | 0 | 0 | 1 | 955 | 30 | 235 | approved | 4 | 1 | 5 | 47.6 | adequate |
72 | ML2_standard | REG_019 | WHO_prequalified_generic | WHO_PQ | solid_oral | oncology | 0 | public_sector_agency | other | 1 | 2,022 | ACTD | 0 | 0 | 1 | 0 | 853 | 48 | 56 | query_raised | 5 | 1 | 5 | 42.7 | adequate |
73 | ML2_standard | REG_025 | generic_suspension_syrup | generic | liquid_oral | ARV_HIV | 0 | local_manufacturer | India | 0 | 2,024 | CTD | 0 | 0 | 1 | 0 | 762 | 31 | 599 | withdrawn | 3 | 1 | 3 | 38.7 | unavailable |
74 | ML2_standard | REG_006 | generic_suspension_syrup | generic | liquid_oral | maternal_reproductive | 0 | local_manufacturer | China | 0 | 2,021 | abbreviated | 0 | 0 | 0 | 1 | 556 | 49 | 270 | approved | 1 | 1 | 3 | 43.4 | unavailable |
75 | ML2_standard | REG_005 | generic_tablet_capsule | generic | solid_oral | antimalarial | 0 | importer_distributor | local_SSA | 0 | 2,024 | ACTD | 0 | 0 | 0 | 1 | 471 | 45 | 480 | approved | 1 | 1 | 3 | 56.7 | unavailable |
76 | ML2_standard | REG_048 | generic_suspension_syrup | generic | liquid_oral | antimalarial | 1 | regional_manufacturer | local_SSA | 0 | 2,022 | ACTD | 0 | 0 | 0 | 0 | 552 | 48 | 229 | query_raised | 2 | 1 | 3 | 58.4 | delayed |
77 | ML2_standard | REG_045 | generic_tablet_capsule | generic | solid_oral | paediatric | 0 | importer_distributor | local_SSA | 0 | 2,023 | ACTD | 0 | 0 | 0 | 0 | 1,150 | 57 | 191 | approved | 5 | 1 | 3 | 49.9 | delayed |
78 | ML2_standard | REG_020 | generic_suspension_syrup | generic | liquid_oral | oncology | 1 | importer_distributor | India | 0 | 2,021 | ACTD | 0 | 0 | 0 | 0 | 338 | 53 | 244 | rejected | 4 | 1 | 5 | 56.6 | unavailable |
79 | ML2_standard | REG_006 | generic_injection | generic | parenteral | analgesic | 0 | public_sector_agency | India | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 979 | 48 | 189 | approved | 5 | 1 | 3 | 58.8 | unavailable |
80 | ML2_standard | REG_054 | generic_tablet_capsule | generic | solid_oral | NCD_diabetes | 0 | importer_distributor | India | 0 | 2,021 | national_format | 0 | 1 | 1 | 0 | 759 | 60 | 33 | query_raised | 2 | 1 | 5 | 51.6 | adequate |
81 | ML2_standard | REG_033 | generic_tablet_capsule | generic | solid_oral | mental_health | 1 | regional_manufacturer | local_SSA | 0 | 2,023 | abbreviated | 0 | 0 | 0 | 1 | 409 | 56 | 57 | query_raised | 0 | 1 | 5 | 39.4 | unavailable |
82 | ML2_standard | REG_029 | generic_suspension_syrup | generic | liquid_oral | oncology | 1 | local_manufacturer | Europe | 0 | 2,020 | CTD | 0 | 0 | 0 | 0 | 666 | 60 | 119 | approved | 2 | 1 | 5 | 54.4 | unavailable |
83 | ML2_standard | REG_011 | generic_tablet_capsule | generic | solid_oral | analgesic | 0 | importer_distributor | Europe | 0 | 2,023 | CTD | 0 | 1 | 0 | 0 | 1,070 | 47 | 153 | withdrawn | 2 | 1 | 5 | 41.4 | unavailable |
84 | ML2_standard | REG_006 | biological_vaccine | biological | parenteral | ARV_HIV | 1 | public_sector_agency | India | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 367 | 38 | 294 | approved | 3 | 1 | 5 | 39.8 | delayed |
85 | ML2_standard | REG_044 | generic_injection | generic | parenteral | dermatology | 1 | public_sector_agency | China | 0 | 2,021 | national_format | 1 | 0 | 0 | 0 | 991 | 45 | 30 | approved | 3 | 1 | 3 | 54.9 | delayed |
86 | ML2_standard | REG_042 | generic_tablet_capsule | generic | solid_oral | oncology | 0 | importer_distributor | India | 0 | 2,022 | ACTD | 0 | 0 | 0 | 1 | 1,031 | 49 | 36 | rejected | 3 | 1 | 5 | 52.5 | delayed |
87 | ML2_standard | REG_005 | generic_tablet_capsule | generic | solid_oral | dermatology | 1 | importer_distributor | India | 0 | 2,024 | ACTD | 0 | 1 | 0 | 1 | 793 | 40 | 244 | withdrawn | 5 | 1 | 5 | 52.1 | delayed |
88 | ML2_standard | REG_050 | generic_tablet_capsule | generic | solid_oral | dermatology | 1 | multinational | India | 0 | 2,023 | CTD | 0 | 0 | 0 | 1 | 1,259 | 38 | 106 | rejected | 3 | 1 | 5 | 61.6 | adequate |
89 | ML2_standard | REG_037 | generic_tablet_capsule | generic | solid_oral | paediatric | 0 | public_sector_agency | Europe | 0 | 2,024 | abbreviated | 0 | 0 | 0 | 0 | 758 | 59 | 30 | withdrawn | 1 | 1 | 3 | 47.4 | adequate |
90 | ML2_standard | REG_020 | generic_tablet_capsule | generic | solid_oral | TB | 1 | local_manufacturer | India | 0 | 2,020 | CTD | 0 | 0 | 0 | 0 | 777 | 42 | 167 | rejected | 6 | 0 | 3 | 65.4 | unavailable |
91 | ML2_standard | REG_002 | generic_injection | generic | parenteral | antibiotic | 1 | importer_distributor | local_SSA | 0 | 2,024 | CTD | 0 | 0 | 1 | 0 | 847 | 53 | 211 | rejected | 3 | 1 | 5 | 50.7 | delayed |
92 | ML2_standard | REG_003 | generic_tablet_capsule | generic | solid_oral | antibiotic | 0 | local_manufacturer | USA | 0 | 2,024 | national_format | 0 | 0 | 0 | 0 | 1,003 | 51 | 259 | approved | 3 | 1 | 5 | 59.4 | adequate |
93 | ML2_standard | REG_028 | generic_tablet_capsule | generic | solid_oral | analgesic | 0 | multinational | other | 0 | 2,021 | CTD | 0 | 0 | 0 | 1 | 573 | 63 | 30 | withdrawn | 1 | 0 | 5 | 43.8 | delayed |
94 | ML2_standard | REG_037 | generic_tablet_capsule | generic | solid_oral | NCD_diabetes | 1 | public_sector_agency | India | 0 | 2,020 | CTD | 0 | 0 | 0 | 1 | 559 | 27 | 1,572 | approved | 3 | 1 | 3 | 50.4 | delayed |
95 | ML2_standard | REG_011 | generic_tablet_capsule | generic | solid_oral | ARV_HIV | 0 | local_manufacturer | India | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 905 | 55 | 357 | query_raised | 2 | 1 | 3 | 50.1 | delayed |
96 | ML2_standard | REG_005 | biosimilar | biosimilar | parenteral | paediatric | 0 | importer_distributor | local_SSA | 0 | 2,024 | CTD | 0 | 0 | 0 | 0 | 866 | 53 | 389 | approved | 2 | 0 | 5 | 41 | adequate |
97 | ML2_standard | REG_011 | generic_suspension_syrup | generic | liquid_oral | dermatology | 0 | regional_manufacturer | India | 1 | 2,024 | CTD | 1 | 0 | 0 | 0 | 962 | 19 | 36 | query_raised | 5 | 1 | 3 | 54.8 | adequate |
98 | ML2_standard | REG_015 | generic_suspension_syrup | generic | liquid_oral | ARV_HIV | 1 | public_sector_agency | India | 1 | 2,022 | CTD | 0 | 0 | 0 | 1 | 668 | 24 | 46 | query_raised | 2 | 1 | 5 | 72.8 | delayed |
99 | ML2_standard | REG_036 | generic_tablet_capsule | generic | solid_oral | antimalarial | 1 | importer_distributor | India | 0 | 2,020 | abbreviated | 0 | 0 | 1 | 1 | 586 | 14 | 696 | query_raised | 4 | 1 | 3 | 63.7 | unavailable |
100 | ML2_standard | REG_007 | generic_injection | generic | parenteral | maternal_reproductive | 1 | local_manufacturer | India | 0 | 2,023 | CTD | 0 | 0 | 0 | 1 | 267 | 65 | 30 | query_raised | 2 | 1 | 3 | 50.8 | unavailable |
Drug Registration & Market Authorization Dataset
Abstract
This dataset provides 30,000 simulated drug registration dossier observations (10,000 per scenario) across three NRA capacity levels in sub-Saharan Africa. Each record represents one registration application with 30+ variables including product type, dossier quality, registration timeline, outcome, reliance pathway usage, and patient access impact. Three scenarios: strong NRA with reliance (38-day median, 91% approval), developing NRA (191-day, 55%), minimal NRA (592-day, 18%).
This dataset is entirely simulated. It must not be used for regulatory or policy decisions.
1. Introduction
Drug registration is the gateway to legal medicine access. In SSA, registration timelines range from months (ML3+ NRAs with reliance pathways) to years (ML1 countries). Only 10-30% of WHO essential medicines are registered in the lowest-income African countries. AMRH and WHO reliance/recognition pathways aim to accelerate access while maintaining quality standards.
2. Parameterization Evidence (v2.0)
| Parameter | Value Used | Source | Year |
|---|---|---|---|
| Median registration 12-36 months SSA | 12-36 mo | WHO | 2023 |
| EML coverage 10-30% in LICs | 10-30% | Lancet Commission | 2017 |
| WHO PQ ~600 products | ~600 | WHO PQ Programme | 2023 |
| AMRH joint assessment 30-50% faster | 30-50% | AMRH/AU-NEPAD | 2023 |
| African pharma market ~$30B | $30B | UNCTAD | 2022 |
3. Validation
4. Usage
from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/drug-registration-authorization", "developing_nra_standard")
df = dataset["train"].to_pandas()
print(df.groupby('outcome').size())
5. References
- WHO (2023). Global landscape of pharmaceutical regulation.
- AMRH/AU-NEPAD. African Medicines Regulatory Harmonization.
- Lancet Commission (2017). Essential Medicines.
- WHO Prequalification Programme.
- UNCTAD (2022). African pharmaceutical market.
Citation
@dataset{esa_drug_reg_2025,
title = {Drug Registration and Market Authorization Dataset},
author = {{Electric Sheep Africa}},
year = {2025},
publisher = {Hugging Face},
url = {https://huggingface.co/datasets/electricsheepafrica/drug-registration-authorization}
}
License
- Downloads last month
- 33